Upstream Bio, Inc.

UPB
$7.51 (+ $0.23 + 3.16%)
Last updated: 2026-07-05 04:01 UTC
UPB Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS91678A1079
CUSIP91678A107
Market Price7.51
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-6.4
Market Cap$1.6B
Book Value7.01
Price to Book4.205
BetaN/A
52w High33.0
52w Low5.14
Next Earnings DateN/A

Upstream Bio, Inc. trades under ticker UPB on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US91678A1079, CUSIP 91678A107.

About the Company
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Price History